TargetTrack | Target Query Results

1 targets match your request

Target ID:JCSG-423098
Source Organism
Sinorhizobium meliloti 1021
Target Name
CP20730C
Target Category
community nominated
Target Rationale
Structural studies of pilus assembly protein CpaE from Caulobacter Crescentus. Proposed by Dr. Lucy Shapiro of Stanford University School of Medicine.
Status
in PDB
Site
JCSG
Site ID
423098
Lab List
GNF,SSRL,UCSD
Structure available
4myr
Remark
Putative CpaE2 pilus assembly protein, response regulator receiver domain, PF00072
URL
http://www1.jcsg.org/...
Last Update
2013-09-27
Project List
PSI-3
Database References
NCBI RefSeq: NP_436101.1, PSICNT: 66, BIG: BIG_267


Targets that contain a matching or similar sequence to your query are listed with the best alignments presented at the top. View the Alignment tab to see how closely a target sequence matches your query.

A target containing one or more sequences may have multiple alignments in this tab.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.